Skip to main content
X4 Pharmaceuticals, Inc logo

X4 Pharmaceuticals, Inc — Investor Relations & Filings

Ticker · XFOR ISIN · US0428731097 LEI · 549300R0UFVPXWP86U94 US Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2020-06-10 Regulatory Filings
Country US United States of America
Listing US XFOR

About X4 Pharmaceuticals, Inc

https://www.x4pharma.com/

X4 Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases of the immune system. The company focuses on diseases resulting from the dysfunction of the CXCR4 pathway, a key signaling pathway for immune cell trafficking. Its lead product, XOLREMDI™ (mavorixafor), is an oral, selective antagonist of the CXCR4 receptor. It is approved for use in patients aged 12 and older with WHIM syndrome (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) to increase the number of circulating neutrophils and lymphocytes. The company's pipeline includes further investigation of mavorixafor for other chronic neutropenic disorders.

Recent filings

Filing Released Lang Actions
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes details about the securities to be registered, the equity incentive plan, and exhibits related to the plan and legal opinions. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration under the Securities Act of 1933. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a full registration statement filing.
2020-06-10 English
FORM 4
Director's Dealing
2020-06-03 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement related to shareholder meetings. It specifically mentions it is a supplement to the Notice of Annual Meeting of Stockholders and Proxy Statement, providing updated information about the change of the 2020 Annual Meeting of Stockholders to a virtual format. The document includes details about registration, voting, and participation in the annual meeting. It is not the proxy statement itself but additional materials supplementing it. Given the nature of the document as proxy solicitation and information materials related to the annual meeting, the appropriate classification is Proxy Solicitation & Information Statement (PSI). The document length is sufficient and contains substantive content related to the proxy materials, not just an announcement or a brief notice, so it is not RPA or RNS.
2020-05-12 English
10-Q
Interim / Quarterly Report Q1 2020
2020-05-07 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 7, 2020. It announces the issuance of a press release containing financial results and business highlights for the quarter ended March 31, 2020. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes the press release as an exhibit. The text explicitly states that the information is being furnished and is not "filed" for certain regulatory purposes, indicating this is an announcement of financial results rather than the full earnings release document itself. Given the short length (3498 characters) and the nature of the content, this fits the profile of an Earnings Release (ER) announcement. However, since the actual financial results are in the press release exhibit and the 8-K is furnishing that release, the best classification is Earnings Release (ER) because the document's primary purpose is to announce quarterly financial results.
2020-05-07 English
FORM 4
Director's Dealing
2020-05-05 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.